Clinphone

Welmedix LLC is a leading provider of specialized home care products designed to clean, protect, and treat fragile skin. Their HomeCare PRO line is specifically formulated to address the unique needs of aging, disabled, and diseased individuals, offering effective solutions to prevent rash, infection, and breakdown. With a focus on gentle yet powerful ingredients, Welmedix products are essential for maintaining the health and resilience of fragile skin. Recognizing that everyday soap, alcohol wipes, hand lotions, and powders can be harmful to fragile skin, Welmedix HomeCare PRO offers a safe and reliable alternative. Their products are carefully developed to provide lasting protection without causing irritation or dryness. With a commitment to quality and effectiveness, Welmedix LLC is dedicated to helping individuals maintain the integrity of their skin and improve their overall well-being.Generated from the website

Based in Princeton, N.J., the New Jersey Hospital Association is a network of acute care hospitals, specialty hospitals, skilled nursing facilities, home health agencies and other health care facilities. The health care centers treat more than 16 million patients annually and respond to over 2.6 million cases in their emergency rooms. It provides a large number of surgeries for the sick and wounded. The hospitals offer a variety of charity care services each year. The hospitals and the care centers provide its services to various conditions of health that include heart attack, heart failure, pneumonia and preventing surgical infections. In addition, the New Jersey Hospital Association oversees the quality of performance of the clinical areas, improves its ongoing staff education and training and shares the modern technology and technical practices throughout the state.

BioWa, Inc. is a New Jersey-based biotech company and a wholly owned subsidiary of Kyowa Kirin Co, Ltd. Established in 2003, BioWa is dedicated to advancing health through innovations in life science and technology, specializing in the out-licensing of Kyowa Kirin's Therapeutic Antibody Technologies, POTELLIGENT and COMPLEGENT. The company's name, BioWa, symbolizes the harmonious fusion of American and Japanese sensibilities, reflecting their earnest mission to enhance the quality of life for all. As the exclusive worldwide licensor of POTELLIGENT Technology, BioWa offers a proprietary technology that generates fucose-free monoclonal antibodies with significantly increased antibody-dependent cellular cytotoxicity (ADCC), bolstering the immune system's ability to eliminate tumor cells. Additionally, BioWa holds the exclusive global license for COMPLEGENT Technology, a robust platform that enhances complement-dependent cytotoxicity (CDC) of therapeutic antibodies. By combining these technologies, BioWa introduces the AcrretaMab platform, a novel class of antibodies designed to combat various life-threatening diseases, including cancer.Generated from the website